Biotransformation of (–)-Isopulegol by Rhodococcus rhodochrous

The ability of actinobacteria of the genus Rhodococcus to biotransform the monoterpenoid (–)-isopulegol has been established for the first time. R. rhodochrous strain IEGM 1362 was selected as a bacterium capable of metabolizing (–)-isopulegol to form new, previously unknown, 10-hydroxy (2) and 10-c...

Full description

Saved in:
Bibliographic Details
Published inPharmaceuticals (Basel, Switzerland) Vol. 15; no. 8; p. 964
Main Authors Ivshina, Irina B., Luchnikova, Natalia A., Maltseva, Polina Yu, Ilyina, Irina V., Volcho, Konstantin P., Gatilov, Yurii V., Korchagina, Dina V., Kostrikina, Nadezhda A., Sorokin, Vladimir V., Mulyukin, Andrey L., Salakhutdinov, Nariman F.
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 03.08.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The ability of actinobacteria of the genus Rhodococcus to biotransform the monoterpenoid (–)-isopulegol has been established for the first time. R. rhodochrous strain IEGM 1362 was selected as a bacterium capable of metabolizing (–)-isopulegol to form new, previously unknown, 10-hydroxy (2) and 10-carboxy (3) derivatives, which may presumably have antitumor activity and act as respiratory stimulants and cancer prevention agents. In the experiments, optimal conditions were selected to provide the maximum target catalytic activity of rhodococci. Using up-to-date (TEM, AFM-CLSM, and EDX) and traditional (cell size, roughness, and zeta potential measurements) biophysical and microbiological methods, it was shown that (–)-isopulegol and halloysite nanotubes did not negatively affect the bacterial cells. The data obtained expand our knowledge of the biocatalytic potential of rhodococci and their possible involvement in the synthesis of pharmacologically active compounds from plant derivatives.
AbstractList The ability of actinobacteria of the genus Rhodococcus to biotransform the monoterpenoid (–)-isopulegol has been established for the first time. R. rhodochrous strain IEGM 1362 was selected as a bacterium capable of metabolizing (–)-isopulegol to form new, previously unknown, 10-hydroxy (2) and 10-carboxy (3) derivatives, which may presumably have antitumor activity and act as respiratory stimulants and cancer prevention agents. In the experiments, optimal conditions were selected to provide the maximum target catalytic activity of rhodococci. Using up-to-date (TEM, AFM-CLSM, and EDX) and traditional (cell size, roughness, and zeta potential measurements) biophysical and microbiological methods, it was shown that (–)-isopulegol and halloysite nanotubes did not negatively affect the bacterial cells. The data obtained expand our knowledge of the biocatalytic potential of rhodococci and their possible involvement in the synthesis of pharmacologically active compounds from plant derivatives.
The ability of actinobacteria of the genus Rhodococcus to biotransform the monoterpenoid (–)-isopulegol has been established for the first time. R . rhodochrous strain IEGM 1362 was selected as a bacterium capable of metabolizing (–)-isopulegol to form new, previously unknown, 10-hydroxy ( 2 ) and 10-carboxy ( 3 ) derivatives, which may presumably have antitumor activity and act as respiratory stimulants and cancer prevention agents. In the experiments, optimal conditions were selected to provide the maximum target catalytic activity of rhodococci. Using up-to-date (TEM, AFM-CLSM, and EDX) and traditional (cell size, roughness, and zeta potential measurements) biophysical and microbiological methods, it was shown that (–)-isopulegol and halloysite nanotubes did not negatively affect the bacterial cells. The data obtained expand our knowledge of the biocatalytic potential of rhodococci and their possible involvement in the synthesis of pharmacologically active compounds from plant derivatives.
The ability of actinobacteria of the genus Rhodococcus to biotransform the monoterpenoid (-)-isopulegol has been established for the first time. R. rhodochrous strain IEGM 1362 was selected as a bacterium capable of metabolizing (-)-isopulegol to form new, previously unknown, 10-hydroxy (2) and 10-carboxy (3) derivatives, which may presumably have antitumor activity and act as respiratory stimulants and cancer prevention agents. In the experiments, optimal conditions were selected to provide the maximum target catalytic activity of rhodococci. Using up-to-date (TEM, AFM-CLSM, and EDX) and traditional (cell size, roughness, and zeta potential measurements) biophysical and microbiological methods, it was shown that (-)-isopulegol and halloysite nanotubes did not negatively affect the bacterial cells. The data obtained expand our knowledge of the biocatalytic potential of rhodococci and their possible involvement in the synthesis of pharmacologically active compounds from plant derivatives.The ability of actinobacteria of the genus Rhodococcus to biotransform the monoterpenoid (-)-isopulegol has been established for the first time. R. rhodochrous strain IEGM 1362 was selected as a bacterium capable of metabolizing (-)-isopulegol to form new, previously unknown, 10-hydroxy (2) and 10-carboxy (3) derivatives, which may presumably have antitumor activity and act as respiratory stimulants and cancer prevention agents. In the experiments, optimal conditions were selected to provide the maximum target catalytic activity of rhodococci. Using up-to-date (TEM, AFM-CLSM, and EDX) and traditional (cell size, roughness, and zeta potential measurements) biophysical and microbiological methods, it was shown that (-)-isopulegol and halloysite nanotubes did not negatively affect the bacterial cells. The data obtained expand our knowledge of the biocatalytic potential of rhodococci and their possible involvement in the synthesis of pharmacologically active compounds from plant derivatives.
Author Korchagina, Dina V.
Luchnikova, Natalia A.
Ivshina, Irina B.
Gatilov, Yurii V.
Sorokin, Vladimir V.
Ilyina, Irina V.
Volcho, Konstantin P.
Maltseva, Polina Yu
Kostrikina, Nadezhda A.
Salakhutdinov, Nariman F.
Mulyukin, Andrey L.
AuthorAffiliation 3 N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry of the Siberian Branch of the Russian Academy of Sciences, 9 Lavrentiev Avenue, 630090 Novosibirsk, Russia; ilyina@nioch.nsc.ru (I.V.I.); volcho@nioch.nsc.ru (K.P.V.); gatilov@nioch.nsc.ru (Y.V.G.); verbenon@mail.ru (D.V.K.); anvar@nioch.nsc.ru (N.F.S.)
1 Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences, Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, 13 Golev Str., 614081 Perm, Russia; luchnikova.n@mail.ru
2 Department of Microbiology and Immunology, Perm State National Research University, 15 Bukirev Str., 614990 Perm, Russia; inbox.98@bk.ru
4 Winogradsky Institute of Microbiology, Research Center of Biotechnology, Russian Academy of Sciences, 60 let Oktyabrya, 7, bld. 2, 117312 Moscow, Russia; nadin-kost@yandex.ru (N.A.K.); vlvlsorokin@gmail.com (V.V.S.); andlm@mail.ru (A.L.M.)
AuthorAffiliation_xml – name: 3 N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry of the Siberian Branch of the Russian Academy of Sciences, 9 Lavrentiev Avenue, 630090 Novosibirsk, Russia; ilyina@nioch.nsc.ru (I.V.I.); volcho@nioch.nsc.ru (K.P.V.); gatilov@nioch.nsc.ru (Y.V.G.); verbenon@mail.ru (D.V.K.); anvar@nioch.nsc.ru (N.F.S.)
– name: 4 Winogradsky Institute of Microbiology, Research Center of Biotechnology, Russian Academy of Sciences, 60 let Oktyabrya, 7, bld. 2, 117312 Moscow, Russia; nadin-kost@yandex.ru (N.A.K.); vlvlsorokin@gmail.com (V.V.S.); andlm@mail.ru (A.L.M.)
– name: 1 Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences, Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, 13 Golev Str., 614081 Perm, Russia; luchnikova.n@mail.ru
– name: 2 Department of Microbiology and Immunology, Perm State National Research University, 15 Bukirev Str., 614990 Perm, Russia; inbox.98@bk.ru
Author_xml – sequence: 1
  givenname: Irina B.
  orcidid: 0000-0003-2558-4789
  surname: Ivshina
  fullname: Ivshina, Irina B.
– sequence: 2
  givenname: Natalia A.
  orcidid: 0000-0002-9292-5726
  surname: Luchnikova
  fullname: Luchnikova, Natalia A.
– sequence: 3
  givenname: Polina Yu
  surname: Maltseva
  fullname: Maltseva, Polina Yu
– sequence: 4
  givenname: Irina V.
  surname: Ilyina
  fullname: Ilyina, Irina V.
– sequence: 5
  givenname: Konstantin P.
  orcidid: 0000-0002-4083-9324
  surname: Volcho
  fullname: Volcho, Konstantin P.
– sequence: 6
  givenname: Yurii V.
  surname: Gatilov
  fullname: Gatilov, Yurii V.
– sequence: 7
  givenname: Dina V.
  surname: Korchagina
  fullname: Korchagina, Dina V.
– sequence: 8
  givenname: Nadezhda A.
  surname: Kostrikina
  fullname: Kostrikina, Nadezhda A.
– sequence: 9
  givenname: Vladimir V.
  surname: Sorokin
  fullname: Sorokin, Vladimir V.
– sequence: 10
  givenname: Andrey L.
  orcidid: 0000-0002-3524-1328
  surname: Mulyukin
  fullname: Mulyukin, Andrey L.
– sequence: 11
  givenname: Nariman F.
  surname: Salakhutdinov
  fullname: Salakhutdinov, Nariman F.
BookMark eNptkd9qFDEUh4NU7B-98QkGvKnC6DlJJpncSLVUXSgIotchk2R2s8xO1mRG6J3v4Bv6JE13K7alVzkk3_lO-J1jcjDG0RPyEuEtYwrebVfYQAtK8CfkCDnldUu5PLhTH5LjnNcAjUSOz8ghE4ANIj0iZx9DnJIZcx_TxkwhjlXsq9O_v_-8rhc5bufBL-NQdVfVt1V00UZr51ylXb1Kcc7PydPeDNm_uD1PyI9PF9_Pv9SXXz8vzj9c1pZzNdWeARrWcQ6-VWBd02InTEuZtBJ9p4SArnWm7ZBK7xQ41rTQW-MoeuUZZSdksfe6aNZ6m8LGpCsdTdC7i5iW2qQp2MHrTsgelEfqymxLUVl0UoEw1gCnpiuu93vXdu423lk_lgiGe9L7L2NY6WX8pRVHyoEVwemtIMWfs8-T3oRs_TCY0ZdMNJUgBYBEVdBXD9B1nNNYorqhBJWUUVEo2FM2xZyT77UN024dZX4YNIK-WbX-v-rS8uZBy7__PwJfA7fDqiQ
CitedBy_id crossref_primary_10_3390_genes15080992
crossref_primary_10_7242_2658_705X_2024_3_2
crossref_primary_10_3390_molecules29143378
crossref_primary_10_3390_ph16091294
crossref_primary_10_3390_ph16060872
crossref_primary_10_3390_microorganisms12122605
Cites_doi 10.1016/j.bmcl.2018.04.057
10.1007/s10593-020-02753-x
10.1016/0031-9422(91)83449-U
10.3109/14756366.2012.727411
10.1016/j.jare.2014.11.009
10.1080/10242420600667684
10.3390/ijms19113522
10.1016/j.watres.2020.116380
10.17485/ijst/2017/v10i21/111382
10.1007/978-3-642-05199-9
10.1002/jsfa.2740101206
10.1139/m87-082
10.3390/polym10020202
10.1007/s13205-021-03108-9
10.3390/nano12060951
10.1016/S1872-2067(19)63305-X
10.4155/fmc-2020-0204
10.1586/ecp.11.6
10.1590/0001-3765201920190105
10.1039/D0RA07739A
10.3390/ijms20194787
10.1016/j.carbpol.2018.06.026
10.1016/j.procbio.2011.06.010
10.3389/fmicb.2019.00077
10.1016/j.fct.2008.06.053
10.1016/j.jhazmat.2017.12.025
10.3144/expresspolymlett.2019.40
10.1016/j.chemosphere.2020.129095
10.1016/j.procbio.2016.10.003
10.1021/acsabm.0c01332
10.1002/tcr.202100194
10.1016/j.scp.2015.07.001
10.1271/bbb.67.475
10.1023/A:1017942114930
10.1016/j.enzmictec.2019.109467
10.3390/molecules23061265
10.1177/0021998318763246
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/ph15080964
DatabaseName CrossRef
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
ProQuest Central Student
ProQuest Research Library
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Acceso a contenido Full Text - Doaj
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1424-8247
ExternalDocumentID oai_doaj_org_article_b67f09e12dc44c219c1d7906aca042ab
PMC9412403
10_3390_ph15080964
GrantInformation_xml – fundername: Ministry of Science and Higher Education of the Russian Federation
  grantid: 075-15-2021-1051
GroupedDBID ---
2WC
53G
5VS
8G5
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACUHS
ADBBV
AEAQA
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
CCPQU
CITATION
DIK
DWQXO
EBD
ESX
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HYE
IAO
IHR
ITC
KQ8
M2O
M48
MK0
MODMG
M~E
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RPM
TUS
3V.
7XB
8FK
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c449t-e301a3b440e890cd581b6a8237c71eb9660b8da8b127ed90d3580fcad21e9e323
IEDL.DBID M48
ISSN 1424-8247
IngestDate Wed Aug 27 01:20:26 EDT 2025
Thu Aug 21 18:13:57 EDT 2025
Fri Jul 11 00:00:37 EDT 2025
Mon Jun 30 14:54:07 EDT 2025
Tue Jul 01 04:13:28 EDT 2025
Thu Apr 24 23:09:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c449t-e301a3b440e890cd581b6a8237c71eb9660b8da8b127ed90d3580fcad21e9e323
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-2558-4789
0000-0002-9292-5726
0000-0002-3524-1328
0000-0002-4083-9324
OpenAccessLink https://www.proquest.com/docview/2706272326?pq-origsite=%requestingapplication%
PMID 36015112
PQID 2706272326
PQPubID 2032350
ParticipantIDs doaj_primary_oai_doaj_org_article_b67f09e12dc44c219c1d7906aca042ab
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9412403
proquest_miscellaneous_2707600719
proquest_journals_2706272326
crossref_citationtrail_10_3390_ph15080964
crossref_primary_10_3390_ph15080964
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20220803
PublicationDateYYYYMMDD 2022-08-03
PublicationDate_xml – month: 8
  year: 2022
  text: 20220803
  day: 3
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Pharmaceuticals (Basel, Switzerland)
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Schewe (ref_32) 2011; 46
Bhatia (ref_5) 2008; 46
Hegazy (ref_14) 2015; 6
ref_12
ref_33
Sultana (ref_2) 2013; 28
Movsowitz (ref_29) 2021; 4
ref_31
Ahn (ref_25) 2020; 186
Sassa (ref_35) 2003; 67
Fernandes (ref_34) 2006; 24
Zaprutko (ref_3) 2020; 12
Shahcheraghi (ref_22) 2022; 12
Le (ref_8) 2020; 10
ref_18
ref_16
ref_38
Ilyina (ref_6) 2018; 28
Calixto (ref_1) 2019; 91
Pavlova (ref_7) 2020; 56
Partovinia (ref_26) 2019; 13
Su (ref_15) 2020; 133
Cheremnykh (ref_20) 2018; 346
Liu (ref_28) 2021; 265
Kholkina (ref_10) 2019; 40
Daughton (ref_11) 2011; 4
Hasan (ref_24) 2018; 52
Sawamura (ref_37) 1976; 40
Rawtani (ref_23) 2012; 30
Tian (ref_27) 2018; 198
Mulyukin (ref_30) 2002; 71
Asakawa (ref_36) 1991; 30
ref_41
Tarasova (ref_19) 2017; 52
Szakonyi (ref_4) 2022; 22
Mrunalini (ref_40) 2017; 10
ref_9
Anteneh (ref_17) 2019; 10
Leder (ref_13) 2015; 2
Shukla (ref_21) 1987; 33
Postgate (ref_39) 1959; 10
References_xml – volume: 28
  start-page: 2061
  year: 2018
  ident: ref_6
  article-title: Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2018.04.057
– volume: 56
  start-page: 936
  year: 2020
  ident: ref_7
  article-title: Synthesis of 1,3-oxazine derivatives based on (−)-isopulegol using the Ritter reaction and study of their analgesic activity
  publication-title: Chem. Heterocycl. Compd.
  doi: 10.1007/s10593-020-02753-x
– volume: 30
  start-page: 3981
  year: 1991
  ident: ref_36
  article-title: Biotransformation of monoterpenoids, (−)- and (+)-Menthols, terpinolene and carvotanacetone by Aspergillus species
  publication-title: Phytochemistry
  doi: 10.1016/0031-9422(91)83449-U
– volume: 28
  start-page: 1113
  year: 2013
  ident: ref_2
  article-title: Enzymatic biotransformation of terpenes as bioactive agents
  publication-title: J. Enzyme Inhib. Med. Chem.
  doi: 10.3109/14756366.2012.727411
– volume: 6
  start-page: 17
  year: 2015
  ident: ref_14
  article-title: Microbial biotransformation as a tool for drug development based on natural products from mevalonic acid pathway: A review
  publication-title: J. Adv. Res.
  doi: 10.1016/j.jare.2014.11.009
– volume: 24
  start-page: 237
  year: 2006
  ident: ref_34
  article-title: Microlitre/millilitre shaken bioreactors in fermentative and biotransformation processes—A review
  publication-title: Biocatal. Biotransformat.
  doi: 10.1080/10242420600667684
– ident: ref_9
  doi: 10.3390/ijms19113522
– volume: 186
  start-page: 116380
  year: 2020
  ident: ref_25
  article-title: Fungal mycelia functionalization with halloysite nanotubes for hyphal spreading and sorption behavior regulation: A new bio-ceramic hybrid for enhanced water treatment
  publication-title: Water Res.
  doi: 10.1016/j.watres.2020.116380
– volume: 10
  start-page: 1
  year: 2017
  ident: ref_40
  article-title: Screening and characterization of lipid inclusions in bacteria by fluorescence microscopy and mass spectrometry as a source for biofuel production
  publication-title: Indian J. Sci. Technol.
  doi: 10.17485/ijst/2017/v10i21/111382
– ident: ref_12
  doi: 10.1007/978-3-642-05199-9
– volume: 10
  start-page: 669
  year: 1959
  ident: ref_39
  article-title: Differential media for sulphur bacteria
  publication-title: J. Sci. Food Agric.
  doi: 10.1002/jsfa.2740101206
– volume: 33
  start-page: 489
  year: 1987
  ident: ref_21
  article-title: Microbial transformation of menthol and menthane-3,4-diol
  publication-title: Can. J. Microbiol.
  doi: 10.1139/m87-082
– ident: ref_33
  doi: 10.3390/polym10020202
– volume: 12
  start-page: 65
  year: 2022
  ident: ref_22
  article-title: Nano-biotechnology, an applicable approach for sustainable future
  publication-title: 3 Biotech.
  doi: 10.1007/s13205-021-03108-9
– ident: ref_31
  doi: 10.3390/nano12060951
– volume: 40
  start-page: 1713
  year: 2019
  ident: ref_10
  article-title: Prins cyclisation of (−)-isopulegol with benzaldehyde over ZSM-5 based micro-mesoporous catalysts for production of pharmaceuticals
  publication-title: Chin. J. Catal.
  doi: 10.1016/S1872-2067(19)63305-X
– volume: 30
  start-page: 282
  year: 2012
  ident: ref_23
  article-title: Multifarious applications of halloysite nanotubes: A review
  publication-title: Rev. Adv. Mater. Sci.
– volume: 12
  start-page: 1743
  year: 2020
  ident: ref_3
  article-title: Anti-COVID drugs: Repurposing existing drugs or search for new complex entities, strategies and perspectives
  publication-title: Future Med. Chem.
  doi: 10.4155/fmc-2020-0204
– volume: 4
  start-page: 211
  year: 2011
  ident: ref_11
  article-title: Green pharmacy and pharmEcovigilance: Prescribing and the planet
  publication-title: Expert Rev. Clin. Pharmacol.
  doi: 10.1586/ecp.11.6
– volume: 91
  start-page: e20190105
  year: 2019
  ident: ref_1
  article-title: The role of natural products in modern drug discovery
  publication-title: An. Acad. Bras. Cienc.
  doi: 10.1590/0001-3765201920190105
– volume: 10
  start-page: 38468
  year: 2020
  ident: ref_8
  article-title: Stereoselective synthesis and application of isopulegol-based bi- and trifunctional chiral compounds
  publication-title: RSC Adv.
  doi: 10.1039/D0RA07739A
– ident: ref_18
  doi: 10.3390/ijms20194787
– volume: 198
  start-page: 191
  year: 2018
  ident: ref_27
  article-title: Enhancing bacterial cellulose production via adding mesoporous halloysite nanotubes in the culture medium
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2018.06.026
– volume: 46
  start-page: 1885
  year: 2011
  ident: ref_32
  article-title: Biooxidation of monoterpenes with bacterial monooxygenases
  publication-title: Process. Biochem.
  doi: 10.1016/j.procbio.2011.06.010
– volume: 10
  start-page: 77
  year: 2019
  ident: ref_17
  article-title: Whole cell actinobacteria as biocatalysts
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2019.00077
– volume: 46
  start-page: S185
  year: 2008
  ident: ref_5
  article-title: Fragrance material review on isopulegol
  publication-title: Food Chem. Toxicol.
  doi: 10.1016/j.fct.2008.06.053
– ident: ref_41
– volume: 346
  start-page: 103
  year: 2018
  ident: ref_20
  article-title: Bioconversion of ecotoxic dehydroabietic acid using Rhodococcus actinobacteria
  publication-title: J. Hazard. Mater.
  doi: 10.1016/j.jhazmat.2017.12.025
– volume: 13
  start-page: 484
  year: 2019
  ident: ref_26
  article-title: Fabrication of novel nanocomposite nanofibrous matrices retaining high concentration of microbial cells for heavy crude oil biodegradation
  publication-title: Express Polym. Lett.
  doi: 10.3144/expresspolymlett.2019.40
– volume: 265
  start-page: 129095
  year: 2021
  ident: ref_28
  article-title: Differential regulation and the underlying mechanisms of clay minerals to Escherichia coli under the stress of polymyxin B: Comparing halloysite with kaolinite
  publication-title: Chemosphere
  doi: 10.1016/j.chemosphere.2020.129095
– ident: ref_38
– volume: 52
  start-page: 1
  year: 2017
  ident: ref_19
  article-title: Cell adaptations of Rhodococcus rhodochrous IEGM 66 to betulin biotransformation
  publication-title: Process. Biochem.
  doi: 10.1016/j.procbio.2016.10.003
– volume: 4
  start-page: 4094
  year: 2021
  ident: ref_29
  article-title: Antibody-functionalized halloysite nanotubes for targeting bacterial cells
  publication-title: ACS Appl. Bio Mater.
  doi: 10.1021/acsabm.0c01332
– volume: 22
  start-page: e202100194
  year: 2022
  ident: ref_4
  article-title: Enantiomeric isopulegol as the chiral pool in the total synthesis of bioactive agents
  publication-title: Chem. Rec.
  doi: 10.1002/tcr.202100194
– volume: 2
  start-page: 31
  year: 2015
  ident: ref_13
  article-title: Putting benign by design into practice-novel concepts for green and sustainable pharmacy: Designing green drug derivatives by non-targeted synthesis and screening for biodegradability
  publication-title: Sustain. Chem. Pharm.
  doi: 10.1016/j.scp.2015.07.001
– volume: 67
  start-page: 475
  year: 2003
  ident: ref_35
  article-title: (+)-Menthol and its hydroxy derivatives, novel fungal monoterpenols from the fusicoccin-producing fungi, Phomopsis amygdali F6a and Niigata 2
  publication-title: Biosci. Biotechnol. Biochem.
  doi: 10.1271/bbb.67.475
– volume: 71
  start-page: 31
  year: 2002
  ident: ref_30
  article-title: Comparative study of the elemental composition of vegetative and dormant microbial cells
  publication-title: Microbiology
  doi: 10.1023/A:1017942114930
– volume: 40
  start-page: 649
  year: 1976
  ident: ref_37
  article-title: Conversion of (−)-menthone by Pseudomonas fluorescens M-2
  publication-title: Agric. Biol. Chem.
– volume: 133
  start-page: 109467
  year: 2020
  ident: ref_15
  article-title: Cutinases as stereoselective catalysts: Specific activity and enantioselectivity of cutinases and lipases for menthol and its analogs
  publication-title: Enzyme Microb. Technol.
  doi: 10.1016/j.enzmictec.2019.109467
– ident: ref_16
  doi: 10.3390/molecules23061265
– volume: 52
  start-page: 3199
  year: 2018
  ident: ref_24
  article-title: A study of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) biofilms’ thermal and biodegradable properties reinforced with halloysite nanotubes
  publication-title: J. Compos. Mater.
  doi: 10.1177/0021998318763246
SSID ssj0057141
Score 2.320534
Snippet The ability of actinobacteria of the genus Rhodococcus to biotransform the monoterpenoid (–)-isopulegol has been established for the first time. R. rhodochrous...
The ability of actinobacteria of the genus Rhodococcus to biotransform the monoterpenoid (-)-isopulegol has been established for the first time. R. rhodochrous...
The ability of actinobacteria of the genus Rhodococcus to biotransform the monoterpenoid (–)-isopulegol has been established for the first time. R ....
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 964
SubjectTerms (–)-isopulegol
Biodegradation
biotransformation
Carbon
Composite materials
Cytotoxicity
Enzymes
halloysite nanotubes
Microorganisms
Microscopy
monoterpenoid
Morphology
Nanoparticles
Physiology
Rhodococcus rhodochrous
SummonAdditionalLinks – databaseName: Acceso a contenido Full Text - Doaj
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Ni9swEBVlT72Ubrel7mYXlZbQhZhYtiJZt-2WLmmhJZQEcjP6chMIdoizh9z6H_Yf9pd0xnY-DIVeejP2HOSnmdEbJL0h5L11IytMzsPU6zzkxprQuDQKnYXUaGJt81q--Nt3MZ7xr_PR_KTVF54Ja-SBG-CGRsg8Up7FznJuIb4sc1JFQlsN_qYNZl9Y8_bFVJODR5Jx1oiRJlDUD9cLlD0Hts47y0-t0t-hlt2DkScrzf1z8qyliPRjM7Rz8sQXL0h_0mhM7wZ0erwyVQ1on06O6tO7C3J7tyy3J2y0LGiZ0w-_fz3ehF8qbNflf5Yranb0xwJKUsiH9qGim_oZe_ZUL8ns_vP00zhs2ySEgIjahh5iVCeG88inKgLwgYkKjSI0VjJvUH7TpE6nhsXSOxU53PnMrXYx88oncfKKnBVl4V8T6jU3wP-wymDcCquF0yIxXmqnnEhZQG726GW21RDHVharDGoJRDo7Ih2QdwfbdaOc8VerO5yEgwWqXdcvwAey1geyf_lAQHr7KczaEKyyWKICMxBGEZC3h88QPLgjogsPgKINbkxKpgIiO1PfGVD3S7Fc1DLcCht3R8mb__EHl-RpjPcq8CxK0iNn282DvwK2szXXtWP_Abv5Ams
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NatwwEBZtcumltGlLnSZFpSU0EBHL1krWKc2WhLTQsIQEcjP6czYQ7O16c9hb3yFv2CfJjFe7G0PpzdgDtmc0n2Y00jeEfHF-4KStBCuCqZiwzjLri5R5B9BoM-Oqjr7417k8uxI_rwfXccGtjdsql5jYAbVvHK6RH2YKCXVh_pdHk98Mu0ZhdTW20HhONgGCC0i-Nocn56OLJRYPFBd8QUqaQ3J_OBkj_TlE7aI3DXVs_b0Qs79B8smMc_qKvIyhIj1e2PY1eRbqLbI3WnBNzw_o5froVHtA9-hozUI9f0O-DW-b2ZOotKlpU9Gvf_887LMfLbbtCjfNHbVzejGG1BRw0d23dNpdY--e9i25Oj25_H7GYrsE5oTQMxbAV01uhUhDoVMwAkSk0iAZjVM8WKThtIU3heWZCl6nHiuglTM-40GHPMvfkY26qcN7QoMRFuJAzDa4cNIZ6Y3MbVDGay8LnpD9pfZKF7nEsaXFXQk5BWq6XGs6IZ9XspMFg8Y_pYZohJUEsl53N5rpTRmdqLRSVakOPPPwxw6w1nGvdCqNM4A9xiZkZ2nCMrpiW64HTkI-rR6DE2FlxNQBFIoyWKBUXCdE9Uzf-6D-k_p23NFxa2zgnebb_3_5B_Iiw5MTuNsk3yEbs-l92IV4ZmY_xkH7CJPL-uM
  priority: 102
  providerName: ProQuest
Title Biotransformation of (–)-Isopulegol by Rhodococcus rhodochrous
URI https://www.proquest.com/docview/2706272326
https://www.proquest.com/docview/2707600719
https://pubmed.ncbi.nlm.nih.gov/PMC9412403
https://doaj.org/article/b67f09e12dc44c219c1d7906aca042ab
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEB9q--KL-InReqwoxUJX87G3mzyIetJShZaj9KBvYb_SKxxJvVzBe_N_8D_0L3Emyd010gffQnYCyczO7G8yu78BeGvd0EpTCJ56XXBhrOHGpSF3FkOjibUtGvrik1N5PBHfL4YXW7Dq39kpsL4ztaN-UpP57P3PH8tP6PAfKePElP3D9ZRIzRGLi3uwgyuSIgc9EetqwlC1HSzpUBdPY6FamtJ_nu0tTA1_fw909rdM3lqDjh7Cgw48si-ttR_Bli8fw964ZZ9eHrDzzWGq-oDtsfGGl3r5BD6PrqrFLZxalawq2Ls_v37v8281NfLyl9WMmSU7m2KyipHS3tRs3lxTN5_6KUyODs-_HvOugQK3QmQL7tF7dWKECH2ahWgWxKhSEz2NVZE3RMxpUqdTE8XKuyx0VBMtrHZx5DOfxMkz2C6r0j8H5rUwiAwp_4iElVZLp2VivNIuczKNAthfaS-3Hbs4NbmY5ZhlkKbzjaYDeLOWvW45Ne6UGpER1hLEg93cqOaXeedWuZGqCDMfxQ6_2GL0tZFTWSi11RiNtAlgd2XCfDW38lgRNzNCSRnA6_UwuhXVSnTpUaEkQyVLFWUBqJ7pey_UHymvpg1Bd0YtvcPkxX9950u4H9ORCtqGkuzC9mJ-418h0FmYAeyMDk_HZ4PmR8GgmdN_AQYXAbM
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5V6QEuiKcIFFgEVFSqVa-9WXsPCAi0SmgbRVUq9ebuy02lyg5xKpQb_4H_wY_il7DjR1JLiFtvlj2S1_P4dsa7-w3AW216mquUebGVqceUVp4yse8Z7aBRBVKnJX3x8YgPTtm3s97ZBvxuzsLgtsoGE0ugNrnGf-R7QYSEum7-5x9n3z3sGoWrq00LjcotDu3yhyvZig_Dr86-74LgYH_yZeDVXQU8zZhYeNa5tAwVY76Nhe_G6hI3LpGzRUfUKmSrVLGRsaJBZI3wDS4UplqagFphQyQ6cJC_yUJXynRgs78_Gp802N-LKKMVCWoYCn9vNkW6dVclsNa0V3YHaKW07Q2ZN2a4g_twr05NyefKlx7Ahs0ewva44rZe7pLJ-qhWsUu2yXjNer18BJ_6l_niRhacZyRPyfs_P3_teMMC24TZi_yKqCU5mbpS2OGwvi7IvLzGXkHFYzi9FUU-gU6WZ_YpECuZcnknVjeUaa4lN5KHykbSCMNj2oWdRnuJrrnLsYXGVeJqGNR0stZ0F96sZGcVY8c_pfpohJUEsmyXN_L5RVIHbaJ4lPrC0sC4L9YO2zU1kfC51NJhnVRd2GpMmNShXyRrR-3C69VjF7S4EiMz6xSKMrggGlHRhahl-taA2k-yy2lJ_y2wYbgfPvv_y1_BncHk-Cg5Go4On8PdAE9t4E6XcAs6i_m1feFyqYV6WTswgfPbjpm_E843hQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VqYS4IJ4iUGARUFGpVrz2Zu09oEJoo4ZCFFWt1JvZl5tKlR3iVCg3_gP_hp_DL-mMH0ktIW69WfZIXs9rZzyz3xDy1ti-ETrlXuxU6nFttKdt7HvWgGvUgTJpCV_8bSwOT_mXs_7ZBvnTnIXBtsrGJ5aO2uYG_5H3gggBdWH_F720bouY7A_3Zj88nCCFldZmnEalIkdu-RPSt-LDaB9k_S4Ihgcnnw-9esKAZziXC8-BeqtQc-67WPqwbgjihEL8FhMxpxG5UsdWxZoFkbPSt1g0TI2yAXPShQh6AO5_M4KsyO-QzcHBeHLc7AP9iHFWAaKGofR7sylCr0PGwFtbYDkpoBXetpszb-x2w_vkXh2m0k-VXj0gGy57SLYnFc71cpeerI9tFbt0m07WCNjLR-Tj4CJf3IiI84zmKX3_99fvHW9U4Mgwd55fUr2kx1NIi8Enm6uCzstrnBtUPCant8LIJ6ST5Zl7SqhTXEMMipkO40YYJawSoXaRstKKmHXJTsO9xNQ45jhO4zKBfAY5naw53SVvVrSzCr3jn1QDFMKKAhG3yxv5_DypDTjRIkp96Vhg4YsN-HnDbCR9oYwCv6d0l2w1IkxqN1Aka6Xtkterx2DAWJVRmQOGIg0WRyMmuyRqib61oPaT7GJaQoFLHB7uh8_-__JX5A7YSvJ1ND56Tu4GeIADm17CLdJZzK_cCwirFvplrb-UfL9tk7kGOsk7ug
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Biotransformation+of+%28%E2%80%93%29-Isopulegol+by+Rhodococcus+rhodochrous&rft.jtitle=Pharmaceuticals+%28Basel%2C+Switzerland%29&rft.au=Ivshina%2C+Irina+B.&rft.au=Luchnikova%2C+Natalia+A.&rft.au=Maltseva%2C+Polina+Yu&rft.au=Ilyina%2C+Irina+V.&rft.date=2022-08-03&rft.issn=1424-8247&rft.eissn=1424-8247&rft.volume=15&rft.issue=8&rft.spage=964&rft_id=info:doi/10.3390%2Fph15080964&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_ph15080964
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1424-8247&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1424-8247&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1424-8247&client=summon